// App-Quantinova.ai

BSH2020‐PO‐091 : An international multicentre study of consecutively diagnosed patients with ALCL: outcomes following first‐line therapy in routine clinical practice

Researchers

Presenter

  • N. Martinez-Calle

Principal Investigators

  • A. A. Kirkwood

  • M. Lamb

  • A. Smith

  • K. Manos

  • C. Shrubsole

  • N. Gray

  • S. Ladani

  • K. Lewis

  • M. Bishton

  • M. Ahearne

  • E. Hawkes

  • W. Osborne

  • G. Colins

  • C. Burton

  • C. P. Fox

Medical Centers

  • Clinical Oncology, Nottingham University Hospitals NHS, Nottingham

  • CRUK and UCL Cancer Trials Centre, UCL Cancer Institute, London

  • Haematological Malignancy Research Network, University of York, York, UK

  • Olivia Newton-John Cancer Research Institute/ Austin Health, Heidelberg, Australia

  • Department of Haematology, Newcastle upon Tyne Hospitals, NHS Trust, Newcastle

  • Dept of Haematology, Oxford University Hospitals NHS Foundation Trust

  • Department of Haematology, Leicester Royal Infirmary, Leicester, United Kingdom

  • Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia

  • Department of Haematology, University Hospitals of Leicester, Leicester

  • Department of Haematology, Olivia Newton‐John Cancer Research Institute, Melbourne, Australia

  • Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds, UK

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Solute Carrier Family 12 Member 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved